NCT03969706: An ongoing trial by Stephen Bagley, MD, MSCE
This trial is ongoing. It must report results 3 weeks, 1 day ago.
Full data
| Full entry on ClinicalTrials.gov | NCT03969706 |
|---|---|
| Title | A Single-Arm, Open-label, Phase II Study Evaluating the Efficacy and Safety of Abemaciclib in Patients with Recurrent Oligodendroglioma |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | May 15, 2019 |
| Completion date | May 15, 2025 |
| Required reporting date | May 15, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | June 3, 2026 |
| Days late | None |